Literature DB >> 2446876

Bile acids in peroxisomal disorders.

J R Van Eldere1, G G Parmentier, H J Eyssen, R J Wanders, R B Schutgens, J Vamecq, F Van Hoof, B T Poll-The, J M Saudubray.   

Abstract

We examined serum bile acids in patients with different peroxisomal disorders. Patients with Zellweger syndrome (n = 23), infantile form of Refsum disease (n = 6) and neonatal adrenoleukodystrophy (n = 4) consistently had increased levels of bile acid precursors. Patients with X-linked adrenoleukodystrophy, (n = 5) classical Refsum disease (n = 3), hyperpipecolic acidaemia (n = 4) and rhizomelic chondrodysplasia punctata (n = 9) did not have increased bile acid precursor levels. Total serum bile acids (41 micrograms ml-1) and the percentage of bile acid precursors (80%) were highest in typical Zellweger patients who died young. Long-living Zellweger patients, neonatal adrenoleukodystrophy patients and infantile Refsum disease patients had, on average, less cholestasis and a lower percentage of bile acid precursors. We also observed that total serum bile acids and the percentage of bile acid precursors decreased with age in long-living Zellweger patients. Screening for bile acid precursors, combined with very long chain fatty acids analysis is, in our experience, an easy and reliable first-line approach to the detection of peroxisomal disorders.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446876     DOI: 10.1111/j.1365-2362.1987.tb01131.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  9 in total

1.  A new peroxisomal disorder: di- and trihydroxycholestanaemia due to a presumed trihydroxycholestanoyl-CoA oxidase deficiency.

Authors:  E Christensen; J Van Eldere; N J Brandt; R B Schutgens; R J Wanders; H J Eyssen
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Di- and trihydroxycholestanaemia in twin sisters.

Authors:  R J Wanders; C W van Roermund; A Schelen; R B Schutgens; J Zeman; V Kozich; J Hyanek; M Casteels; G P Mannaerts
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 3.  The inborn errors of peroxisomal beta-oxidation: a review.

Authors:  R J Wanders; C W van Roermund; R B Schutgens; P G Barth; H S Heymans; H van den Bosch; J M Tager
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  A new variant of Zellweger syndrome with normal peroxisomal functions in cultured fibroblasts.

Authors:  R B Schutgens; R J Wanders; C Jakobs; M Arslan-Kirchner; K Miller; P Wieacker; D Hunnemann; P Hurter; M von Schutz
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 5.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 6.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 7.  Bile acids: the role of peroxisomes.

Authors:  Sacha Ferdinandusse; Simone Denis; Phyllis L Faust; Ronald J A Wanders
Journal:  J Lipid Res       Date:  2009-04-08       Impact factor: 5.922

8.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

9.  Cholic acid therapy in Zellweger spectrum disorders.

Authors:  Kevin Berendse; Femke C C Klouwer; Bart G P Koot; Elles M Kemper; Sacha Ferdinandusse; Kiran V K Koelfat; Martin Lenicek; Frank G Schaap; Hans R Waterham; Frédéric M Vaz; Marc Engelen; Peter L M Jansen; Ronald J A Wanders; Bwee Tien Poll-The
Journal:  J Inherit Metab Dis       Date:  2016-07-28       Impact factor: 4.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.